Xavier Jacq
Almac (United Kingdom)(GB)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Cancer-related Molecular Pathways, Genomics and Chromatin Dynamics, Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors
Most-Cited Works
- → Deubiquitylating enzymes and drug discovery: emerging opportunities(2017)910 cited
- → Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor(1994)402 cited
- → Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells(2009)318 cited
- → Functional Proteomics Mapping of a Human Signaling Pathway(2004)314 cited
- → Function of TAFII-containing complex without TBP in transcription by RNA polymerase II(1998)249 cited
- → Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): A Potent and Selective Inhibitor of ATR Protein Kinase with Monotherapy in Vivo Antitumor Activity(2013)214 cited
- → Ribosomal Protein S7 Is Both a Regulator and a Substrate of MDM2(2009)197 cited
- → The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression(2007)168 cited
- → Ribosomal Proteins RPL37, RPS15 and RPS20 Regulate the Mdm2-p53-MdmX Network(2013)166 cited
- → The N-terminal domain of the human TATA-binding protein plays a role in transcription from TATA-containing RNA polymerase II and III promoters.(1994)119 cited